News:   Sobi is an international biopharmaceutical company focused on rare diseases. We are dedicated to providing access to innovative treatments that transform life for people with rare diseases.

Sobi at a glance

At Sobi, we are transforming life for people with rare diseases. As an international biopharmaceutical company, we provide access to innovative treatments in the areas of haematology, immunology and specialty care.

  • Two therapeutic areas – Haematology and Immunology – and a portfolio of products within Specialty Care
  • Our extended half-life factor replacement treatments are the most prescribed treatments for haemophilia A and B respectively in several markets
  • A strong portfolio of on-market products, and an extensive portfolio of pre-market assets
  • An international biopharmaceutical company covering the entire value chain
  • We put our focus where we can have the greatest impact, in late-stage research and development, and in patient access and commercialisation
  • Revenue of SEK 15.3 bn for the full year 2020
  • Global Head Office in Stockholm, with offices in more than 30 countries, delivering treatments to patients in more than 70 countries
  • Approximately 1,500 employees globally

Rare diseases

There are thought to be around 6,000 distinct rare diseases, affecting more than 300 million people around the world. Yet around 95 per cent of rare diseases currently have no approved treatment.

95% of rare diseases currently have no approved treatment

300 million people affected

75% of rare diseases affect children

The rare disease space is unlike any other in medicine. In Europe, a rare disease is defined as one affecting fewer than one person per 2,000. In the US, the Orphan Drug Act of 1983 defines a rare disease as a condition affecting fewer than 200,000 people.

High unmet medical need

An estimated 75 per cent of identified rare diseases affect children, often having a devastating effect on life expectancy and quality of life. Around 30 per cent of children diagnosed with a rare disease will not live to see their fifth birthday. The severe nature of many rare diseases often leads to high levels of distress for patients and their families, with an accompanying high treatment burden.

Around 80 per cent of rare diseases are inherited rather than acquired: they involve a defect in the genes that tell our bodies how to work. As a result, the body may fail to produce an essential enzyme or protein, for example, or its own immune defences may attack its own systems.

Many physicians may never have seen a specific rare condition before; as a result, many cases can go undiagnosed for years.

Rare challenges

The rare disease landscape presents specific scientific, medical and commercial challenges. They range from understanding the biology of a disease, identifying molecules that can become successful treatments, developing the complex biopharmaceutical processes to manufacture a drug, designing and running clinical trials in extremely small patient populations, obtaining regulatory approvals, negotiating pricing and reimbursement, through to working with healthcare professionals and patients to ensure access for the people who need the treatment.

Such treatments are referred to as “orphan drugs,” intended to treat diseases so rare that companies would be reluctant to develop them under normal market conditions.

Therapeutic areas

Our therapies are concentrated within the areas of haematology, immunology and specialty care.

Within haematology we provide extended half-life recombinant replacement clotting factor treatments for haemophilia A and haemophilia B, and a treatment for thrombocytopenia, a condition characterised by abnormally low levels of platelets in the blood.

The field of immunology has long been at the heart of what we do at Sobi, allowing us to gain extensive experience over many years. Our Immunology portfolio allows the treatment of serious, disabling or even life-threatening diseases.

We also provide important specialty treatments in the area of genetics and metabolism.


The area of haematology covers a wide range of conditions, including those involving red and white blood cells, coagulation and platelets, and bone marrow.

Haematology | Sobi


The field of immunology has long been at the heart of what we do at Sobi, allowing us to gain extensive experience over many years.

Immunology | Sobi

Specialty Care

We provide products for the treatment of genetic and metabolic diseases as well as a number of specialist indications.

Specialty Care portfolio | Sobi

Research and development

We bring new treatments to market, expand our existing products into new indications and regions where they address unmet medical need, and gather real-world evidence for available products.

Our R&D is focused on late-stage research within the areas of Haematology and Immunology, where our pre-market assets represent considerable value.


From desert to forest - Minister for Foreign Affairs saw the result

News:  The Minister for Foreign Affairs, Ann Linde, visited the Forest. It was during her time as the Minister for Trade that Sweden’s Expo journey began in 2017. Last time she was at the pavilion it was only desert.

Nordic piano concert for peace

News:  A peace concert with piano music from the Nordic countries was held at the Swedish pavilion, as part of the “Nordic Piano Music Week” at Expo . “The special thing with visiting Expo 2020 Dubai is that we spread the Nordic music”, says the Swedish pianist John Nalan.

The Green Skeikh visited the pavilion

News:  "The Green Sheikh" of the UAE, His Highness Sheikh Abdul Aziz bin Ali Al Nuaimi, entertained visitors at the Swedish pavilion with a talk as part of the series of speaking events during Water Week.

She will be representing UAE in the "Stockholm Junior Water Prize"

News:  Mishal Faraz was the winner of Water Alliance Associatios "RE-NEW Our World Student Water Innovation Challenge 2022". On Thursday she presented her "The Water Bottle Project" at the Swedish pavilion.

Electrical boats invented in Sweden

News:  The Water Week at the Swedish pavilion ha begun. A serious of events is taking place on the Co-creation stage. On Thursday Konrad Bergström, founder of X Shore, who makes hundred percent electrical boats.

Event to raise awareness about importance of forests

News:  “The forestry sector is a sector that can eventually make a huge difference”, says Ismahane Elouafi, Chief Scientist at Food and Agriculture Organization (FAO) and moderator of the event that took place at the Swedish pavilion on the International Day of Forests.

Join the event on International Day of Forests

News:  The International Day of Forests will be celebrated in the pavilion on March 21. In the video you will hear Fredrik Ingemarson, Moderator of the International Day of Forests, talk about some of the highlights.

Regional meeting for Swedish ambassadors

News:  Swedish Ambassadors to the Middle East region had their regional meeting at the Swedish pavilion. It was an opportunity for them to meet but also visit their second countries pavilions.

Swedish cuisine - check out tutorials and innovations

News:  What do you know about the traditional Swedish cuisine and the new innovative food technology? Find out in the videoclip.